Rikard Akhtarzand, CEO of ADDvise Group AB (publ) (“ADDvise” or the “Company”), has informed the Company that he has sold 2,500,000 Class B shares in ADDvise, representing approximately 1.3% of total outstanding shares and 18.1% of his total shareholding in the Company, and that he has entered a 180-day lock-up agreement for his remaining shares.…
Read moreADDvise Group has today entered into a share purchase agreement with the owners of Diabetic Supplies Inc. (“Diabetic Supplies”) regarding the acquisition of all shares of Diabetic Supplies in accordance with the letter of intent previously communicated. Closing of the acquisition is expected to take place at the beginning of September 2023. Diabetic Supplies’ revenue…
Read moreADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Tecnimont. The order involves the design endorsement, supply, and installation of multiple cleanroom facilities as part of a larger industrial project. The order is worth approximately USD 4 million. Tecnimont, a subsidiary of Maire, is a leading integrated engineering and construction services and…
Read moreADDvise recruits Oliver Humlen as new CFO and member of the executive management team. Oliver has more than a decade of experience from investment banking. He joins ADDvise from Pareto Securities where he has been working within Debt Capital Markets for the past nine years, of which six as Partner. Prior to that, he worked…
Read moreApril-June 2023 Net revenue for the period was SEK 344.4 million (231.9), an increase of 48.5%. Organic growth was 10.4%. Orders received for the period was SEK 319.3 million (260.9), an increase of 22.4%. Organic growth was 15.7%. EBITDA for the period was SEK 121.6 million (34.3) Profit/loss for the period was SEK 3.2 million…
Read moreThe preliminary results for ADDvise Group for the second quarter of 2023 significantly deviate from what ADDvise assesses as the market expectations. SEK million Q2 2023 Q2 2022 LTM June 2023 Net sales 342.7 231.9 1,206.0 Gross profit 232.9 139.9 768.0 Gross margin % 68.0% 60.3% 63.7% EBITDA 121.0 34.3 333.7 EBITDA margin % 35.3%…
Read moreStockholm, July 6, 2023 Invitation to presentation of interim report April 1 – June 30, 2023 Media, investors and analysts are on the same day invited to attend a presentation of the interim report April 1 – June 30, 2023 at July 20 13:00 (CEST), 07:00 AM (EST). The CEO, Rikard Akhtarzand, will present the…
Read moreOn May 26, 2023, ADDvise Group AB (publ) (“ADDvise”) successfully issued senior secured bonds in an initial amount of SEK 1,000 million, under a total framework of SEK 2,000 million (the “Bonds”). Pursuant to the terms and conditions for the Bonds, ADDvise has undertaken to apply for admission to trading of the Bonds on the…
Read moreADDvise has signed a Letter of Intent with the shareholders of Innovative Endoscopy Components, LLC. (”IEC”) regarding an acquisition of all shares in IEC. IEC is an international provider of endoscopy equipment and endoscopy spare parts based in Fort Lauderdale, Florida, USA. The company manufactures, supplies and repairs OEM and aftermarket parts to the endoscopy…
Read moreADDvise Group AB (publ) (the “Company”) announced on 12 May 2023 that it will redeem in full all of its outstanding bonds 2021/2024 with ISIN SE0015222088 (the “Bonds” and “Early Redemption”). The Early Redemption was conditional upon the successful issuance of new bonds as announced by the Company through a press release on 11 May…
Read moreThe Board of ADDvise Group AB has decided to update the long-term financial targets for EBITDA margin and revenue growth based on the strong financial performance and the visibility on the upcoming quarters. The EBITDA margin target has been increased from 20% to 28 % and the annual growth target from 25% to 30 %.…
Read moreADDvise Group AB (publ) (the “Company”) announces today that it will redeem in full its outstanding bond loan with ISIN SE0015222088 (the “Bonds” and “Early Redemption”) subject to the successful issuance of new bonds as announced by the Company through a press release on 11 May 2023. Provided that the conditions for Early Redemption are…
Read moreADDvise Group’s subsidiary Sonesta Medical AB extends the agreement with Laborie Medical Technologies (“Laborie”). The agreement is giving Laborie the right to sell Sonesta Medical’s urology- and gynecology patient positioning equipment and video fluoroscopy tables worldwide, with an exclusive right to distribute in USA and some European countries. Laborie commits to a minimum volume of…
Read moreADDvise Group AB (publ) (the “Company”) announces today that it has successfully placed senior secured bonds in an amount of SEK 1,000 million under a framework of SEK 2,000 million with a tenor of 3 years (the “New Bonds” or the “Bond Issue”). The New Bonds will carry floating rate interest of STIBOR 3m plus…
Read moreADDvise has signed a Letter of Intent with the shareholders of Kolplast CI S.A. (”Kolplast”) regarding an acquisition of all shares in Kolplast. Kolplast is a Brazilian manufacturer of MedTech equipment based in São Paulo, Brazil. The company produces disposable medical devices, MedTech equipment, laboratory equipment, and liquid-based cytology products. The company is the market…
Read moreADDvise Group AB (publ), reg. no. 556363–2115, has held its annual general meeting on May 5, 2023 at 10.00 a.m. at Grev Turegatan 30 in Stockholm. At the meeting, the following resolutions were, amongst others, adopted. Disposition of the Company’s earnings The annual general meeting resolved that no dividend shall be paid to the shareholders…
Read moreFurther to recent communication, ADDvise Group AB (publ) (“ADDvise”) has mandated Pareto Securities AB and Skandinaviska Enskilda Banken AB (publ) to arrange a series of fixed income investor meetings starting on 8 May 2023. Subject to inter alia market conditions, a senior secured bond issue in an expected amount of SEK 1 billion and with…
Read moreNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.…
Read moreNOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, NEW ZEALAND, HONG KONG, JAPAN, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, BELARUS, RUSSIA OR ANY OTHER JURISDICTION WHERE SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL OR WOULD REQUIRE REGISTRATION OR ANY OTHER MEASURES.…
Read moreJanuary-March 2023 Net revenue for the period was SEK 310.5 million (162.4), an increase of 91.2%. Organic growth was 19.7%. Orders received for the period was SEK 340.3 million (130.8), an increase of 160.2%. Organic growth was 86.5%. EBITDA for the period was SEK 84.2 million (21.2) Profit/loss for the period was SEK 35.6 million…
Read moreMedia, investors and analysts are on the same day invited to attend a presentation of the interim report January 1 – March 31, 2023 at April 20 13:00 (CEST), 07:00 AM (EST). The CEO, Rikard Akhtarzand, will present the report in a webcast and telephone conference. Webcast If you wish to participate via webcast, please…
Read moreToday, ADDvise Group AB is publishing the annual report and the sustainability report for 2022. The annual report and the sustainability report are available on ADDvise website: www.addvisegroup.com. The annual report and sustainability report are published in Swedish and English. The Swedish versions represent the originals. For further information, please contact: Rikard Akhtarzand, CEO…
Read moreADDvise Group AB (publ), reg. no. 556363–2115 (the "Company" and "ADDvise"), hereby convenes the annual general meeting to be held on May 5, 2023 at 10:00 a.m. at Grev Turegatan 30 in Stockholm. Registration for the meeting will begin at 09:30 a.m. Registration and notification Shareholders wishing to attend the annual general meeting must:…
Read moreADDvise Group AB (publ) (the "Company") issued on 16 December 2022 a senior secured bond loan of SEK 150,000,000 within a total framework amount of SEK 650,000,000 on the Swedish bond market. The bonds carry a floating rate interest of STIBOR 3m + 7.25 per cent per annum and matures May 21, 2024. The Company…
Read moreOctober–December 2022 Net revenue for the period was SEK 320.3 million (155.0), an increase of 106.6 %. Organic growth was 5.5 %. Orders received for the period was SEK 517.7 million (177.6), an increase of 191.5 %. Organic growth was 7.7 %. Adjusted EBITDA for the period was SEK 85.8 million (19.0) EBITDA for the…
Read moreThe Board of Directors of ADDvise Group has adopted financial targets for the financial year 2023: – Net sales pro forma rolling 12 months shall by the end of the year reach SEK 1.6 billion. – EBITDA pro forma rolling 12 months shall by the end of the year reach SEK 330 million. The below…
Read moreADDvise Group has signed a Letter of Intent with the shareholder of Diabetic Supplies Inc. (”Diabetic Supplies” or the “Company”) regarding an acquisition of all shares in Diabetic Supplies. Diabetic Supplies is based in Columbus, Ohio, USA and is a distributor of medical devices for diabetic patients. The Company distributes, among other things, continuous glucose…
Read moreADDvise Group AB (publ)’s subsidiary Hettich Labinstrument AB has received an allocation decision from Region Västra Götaland worth approximately SEK 48 million. The allocation decision consists of delivery of equipment for blood- and urine specimen collection during a four-year period starting May 2023. The allocation decision can be appealed up until February 25, 2023. For…
Read moreTo the annual general meeting (AGM) of ADDvise Group AB (publ) on 5 May 2023, the nomination committee has decided to propose re-election of Fredrik Celsing, Staffan Torstensson, Erland Pontusson, Johanne Brændgaard and Anna Ljung as members of the board of directors. It is proposed that Staffan Torstensson is re-elected chairman of the board of…
Read moreADDvise Group has signed a Letter of Intent with the shareholder of X-Ray Cassette Repair Company Inc (”Reina Imaging”) regarding an acquisition of all shares in Reina Imaging. Reina Imaging is an international medtech equipment manufacturer based in Crystal Lake, Illinois, USA. The company produces digital x-ray panel holders and related imaging products primarily for…
Read moreThe preliminary result for ADDvise Group for the full year 2022 significantly deviates from what ADDvise Group considers to be current market expectations. [image] The net sales pro forma full year 2022 rolling 12 months amounted to SEK 1,097 million with an adjusted EBITDA pro forma of SEK 241 million. The financial targets for the…
Read moreADDvise Group AB’s subsidiary Poly Pharmaceuticals Inc has received an order from AxisCare Health Logistics Inc, a company distributing equipment and medical supplies to hospitals, clinics, medical offices and medical equipment suppliers. The order is worth approximately USD 3.5 million. The order consists of delivery of the prescription dietary supplemental Folite, developed and manufactured by…
Read moreADDvise Group AB’s subsidiary MRC Systems FZE has received an order from Nasser Saeed Al Hajri & Partners Contracting (NHS & Partners), a leading construction contractor in the United Arab Emirates. The order is worth approximately USD 1.8 million. The order involves the detailed design, supply and installation of an ISO 8 and ISO 7…
Read moreADDvise Group’s order intake during the fourth quarter of 2022 amounted to SEK 524.0 million, an increase of 195.0 percent on the same period for the previous year. Order intake in the same quarter of the previous year amounted to SEK 177.6 million. 7.7 percent of the increase in order intake was organic. Order intake…
Read more